Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway.

Civantos, Esther; Bosch, Enrique; Ramirez, Elisa; Zhenyukh, Olha; Egido, Jesús; Lorenzo, Oscar; Mas, Sebastián.

Afiliação

Civantos E; Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Autonoma University.
Bosch E; CIBERDEM (Biomedical Research Centre in Diabetes and Associated Metabolic Disorders), Madrid, Spain.
Ramirez E; Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Autonoma University.
Zhenyukh O; Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Autonoma University.
Egido J; Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Autonoma University.
Lorenzo O; Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Autonoma University.
Mas S; CIBERDEM (Biomedical Research Centre in Diabetes and Associated Metabolic Disorders), Madrid, Spain.

Diabetes Metab Syndr Obes ; 10: 207-222, 2017.

Article em En | MEDLINE | ID: mdl-28652790